Sound View Wealth Advisors Group LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.4% in the 1st quarter, Holdings Channel reports. The firm owned 4,157 shares of the healthcare conglomerate’s stock after acquiring an additional 213 shares during the quarter. Sound View Wealth Advisors Group LLC’s holdings in UnitedHealth Group were worth $1,547,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the business. Norges Bank acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $3,397,896,000. Viking Global Investors LP acquired a new stake in UnitedHealth Group in the 4th quarter valued at $979,682,000. Price T Rowe Associates Inc. MD lifted its stake in UnitedHealth Group by 5.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 38,003,233 shares of the healthcare conglomerate’s stock valued at $13,318,678,000 after acquiring an additional 1,881,407 shares in the last quarter. Morgan Stanley grew its holdings in UnitedHealth Group by 14.1% during the 4th quarter. Morgan Stanley now owns 7,989,764 shares of the healthcare conglomerate’s stock valued at $2,801,850,000 after buying an additional 986,472 shares in the last quarter. Finally, Alliancebernstein L.P. lifted its holdings in UnitedHealth Group by 5.2% in the fourth quarter. Alliancebernstein L.P. now owns 11,485,225 shares of the healthcare conglomerate’s stock valued at $4,027,639,000 after acquiring an additional 569,142 shares during the period. Hedge funds and other institutional investors own 86.03% of the company’s stock.
A number of equities analysts have recently commented on UNH shares. Argus upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $450.00 target price for the company in a report on Tuesday, April 27th. Morgan Stanley raised their price target on UnitedHealth Group from $462.00 to $515.00 and gave the stock an “overweight” rating in a research note on Thursday, April 22nd. Bank of America reaffirmed a “buy” rating and set a $415.00 target price on shares of UnitedHealth Group in a research report on Thursday, January 21st. Credit Suisse Group boosted their price target on UnitedHealth Group from $415.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, April 22nd. Finally, BMO Capital Markets boosted their price target on UnitedHealth Group from $410.00 to $435.00 and gave the company a “market perform” rating in a research note on Thursday, April 22nd. Three investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $409.61.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Wednesday, April 14th. The healthcare conglomerate reported $5.31 earnings per share for the quarter, topping the consensus estimate of $4.38 by $0.93. The company had revenue of $70.20 billion during the quarter, compared to analyst estimates of $69.13 billion. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The firm’s revenue for the quarter was up 9.0% compared to the same quarter last year. During the same period in the prior year, the business posted $3.72 earnings per share. On average, analysts forecast that UnitedHealth Group Incorporated will post 16.75 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 23rd. Shareholders of record on Monday, March 15th were paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.23%. The ex-dividend date of this dividend was Friday, March 12th. UnitedHealth Group’s dividend payout ratio is presently 33.09%.
In other UnitedHealth Group news, EVP Patricia L. Lewis sold 3,000 shares of the business’s stock in a transaction on Friday, April 16th. The stock was sold at an average price of $389.99, for a total value of $1,169,970.00. Following the completion of the transaction, the executive vice president now directly owns 9,214 shares in the company, valued at approximately $3,593,367.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Thomas E. Roos sold 619 shares of the business’s stock in a transaction on Tuesday, February 9th. The shares were sold at an average price of $323.90, for a total value of $200,494.10. Following the completion of the transaction, the chief accounting officer now owns 31,908 shares of the company’s stock, valued at $10,335,001.20. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 20,420 shares of company stock worth $7,532,962. 0.80% of the stock is owned by insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.
Further Reading: What is Compound Annual Growth Rate (CAGR)?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.